期刊
MULTIPLE SCLEROSIS JOURNAL
卷 24, 期 13, 页码 1776-1778出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458518771276
关键词
Multiple sclerosis; alemtuzumab; sarcoidosis; immune system; immunotherapy; lymphocytes
Background: Understanding the long-term effect of alemtuzumab on the immune system of multiple sclerosis (MS) patients is crucial. Objective: To report a case of acute sarcoidosis (Lofgren's syndrome) in a relapsing-remitting MS patient, 1.5 years after the second course of alemtuzumab treatment. Case report: Sarcoidosis was confirmed dermatohistologically, radiologically, and serologically. Analysis of the lymphocyte subpopulations showed a persistent effect of alemtuzumab treatment (CD4/CD8 ratio increased, absolute lymphocyte count of CD19-positive cells increased while CD3/4/8-positive cells were decreased). Conclusion: Our case highlights the profound effect of alemtuzumab on the immune system and its possible risk for autoimmune complications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据